Conference Coverage

New remote monitoring system lessens symptoms in head and neck cancer


 

REPORTING FROM ASCO 2018


“This is yet another application of technology-enabled sharing of information generated at home,” said ASCO President Bruce E. Johnson, MD, FASCO, noting that a similar study last year showed better patient-reported experience and overall survival.

Such technology will likely be increasingly used to obtain timely information that ultimately leads to a reduction in complications, he speculated.

“This information in head and neck cancer is particularly important because patients commonly get a lot of side effects when attempting to swallow enough fluids, such that some centers end up putting a feeding tube into the stomach because it’s so difficult to swallow,” added Dr. Johnson, who is also a professor of medicine at the Dana-Farber Cancer Institute and a leader of the Dana-Farber/Harvard Cancer Center Lung Cancer Program, Boston. “So this is a particularly important clinical application in cancer.”

Study details

The trial population consisted of 357 patients undergoing radiation therapy for head and neck cancer. “We believe that this is the first and largest study of its kind in head and neck cancer,” Dr. Peterson said.

Pages

Recommended Reading

Management of tonsillar carcinoma with advanced radiation therapy and chemotherapy techniques
MDedge Hematology and Oncology
Cancer patients with TKI-induced hypothyroidism had better survival rates
MDedge Hematology and Oncology
ASCO larynx-preservation guidelines reflect important practice changes
MDedge Hematology and Oncology
New and improved classifiers may sharpen thyroid nodule diagnosis
MDedge Hematology and Oncology
Pembrolizumab plus SBRT shows promise for advanced solid tumors
MDedge Hematology and Oncology
Recurrent head and neck cancer presenting as a large retroperitoneal mass
MDedge Hematology and Oncology
When it comes to thyroid cancer follow-up, serum microRNA profiles have earned new respect
MDedge Hematology and Oncology
Probe linked to smartphone found effective in diagnosing oral cancer
MDedge Hematology and Oncology
Resolution of refractory pruritus with aprepitant in a patient with microcystic adnexal carcinoma
MDedge Hematology and Oncology
FDA approves dabrafenib/trametinib for BRAF-positive anaplastic thyroid cancer
MDedge Hematology and Oncology